26 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
15
Bacterial Peptide deformylase inhibition of cyano substituted biaryl analogs: Synthesis, in vitro biological evaluation, molecular docking study and in silico ADME prediction.

Y.B. Chavan College of Pharmacy
3
Identification of novel aminopiperidine derivatives for antibacterial activity against Gram-positive bacteria.

Research Laboratories Ildong Pharmaceutical
25
Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.

Seoul National University
1
Macrolactin N, a new peptide deformylase inhibitor produced by Bacillus subtilis.

Korea Research Institute of Bioscience and Biotechnology
40
Acylprolinamides: a new class of peptide deformylase inhibitors with in vivo antibacterial activity.

Glaxosmithkline
3
Flavimycins A and B, dimeric 1,3-dihydroisobenzofurans with peptide deformylase inhibitory activity from Aspergillus flavipes.

Korea Research Institute of Bioscience and Biotechnology
24
Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.

Centre National De La Recherche Scientifique
26
Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.

F. Hoffmann-La Roche
36
Structure--activity relationships of the peptide deformylase inhibitor BB-3497: modification of the P2' and P3' side chains.

British Biotech Pharmaceuticals
14
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.

Memorial Sloan-Kettering Cancer Center
33
Peptidomimetic inhibitors of bacterial peptide deformylase.

Vernalis (R&D)
20
Peptide deformylase inhibitors with non-peptide scaffold: synthesis and structure-activity relationships.

Seoul National University
14
Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological results.

Novartis Institute For Tropical Diseases
3
Design, Synthesis, and Biological Evaluation of 1,3,4-Thiadiazole Derivatives as Novel Potent Peptide Deformylase Inhibitors for Combating Drug-Resistant Gram-Positive and -Negative Bacteria.

Henan Normal University
4
Macrolactins O-R, glycosylated 24-membered lactones from Bacillus sp. AH159-1.

Korea Research Institute of Bioscience and Biotechnology
11
Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.

The Ohio State University
36
Identification of novel potent bicyclic peptide deformylase inhibitors.

Genomics Institute of The Novartis Research Foundation
38
Peptide deformylase inhibitors with activity against respiratory tract pathogens.

British Biotech Pharmaceuticals
2
Structure-based design of a macrocyclic inhibitor for peptide deformylase.

The Ohio State University
16
2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitors.

F. Hoffmann-La Roche
14
Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.

Pharmacia
22
Discovery of piperazic acid peptide deformylase inhibitors with in vivo activity for respiratory tract and skin infections.

Glaxosmithkline
2
H-phosphonate derivatives as novel peptide deformylase inhibitors.

Ohio State University
16
A novel class of inhibitors of peptide deformylase discovered through high-throughput screening and virtual ligand screening.

Stine-Haskell Research Center
6
Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3.

Glaxosmithkline